| Cardiovascular Risk Management |
1 |
1 |
| Atrial Fibrillation |
0 |
1 |
| Coronary Heart Disease Risk Factors |
0 |
0.75 |
| Coronary Artery Disease (CAD) |
0 |
0.74 |
| Cardiovascular disease |
0 |
0.63 |
| Hypertriglyceridemia |
0 |
1 |
| Cardiometabolic Risk Factors |
0 |
0.39 |
| Lipids Management |
0 |
0.33 |
| Adverse Effects |
0 |
1 |
| Blood |
0 |
0.21 |
| Clinical Research |
0 |
0.21 |
| Europe |
0 |
0.21 |
| Heart |
0 |
0.21 |
| Meta-Analysis |
0 |
0.21 |
| Nutrition |
0 |
0.21 |
| Triglycerides |
0 |
0.21 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Patient Safety |
0 |
0.95 |